Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
18.5M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
8.62M
-
Shares change
-
-260K
-
Total reported value, excl. options
-
$109M
-
Value change
-
-$2.07M
-
Put/Call ratio
-
0.27
-
Number of buys
-
33
-
Number of sells
-
-37
-
Price
-
$12.65
Significant Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q3 2025
102 filings reported holding CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.62M shares
of 18.5M outstanding shares and own 46.55% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (2.38M shares), ORBIMED ADVISORS LLC (1.17M shares), Octagon Capital Advisors LP (1.12M shares), VANGUARD GROUP INC (612K shares), Prosight Management, LP (343K shares), Exome Asset Management LLC (230K shares), BlackRock, Inc. (227K shares), COMERICA BANK (200K shares), ARMISTICE CAPITAL, LLC (192K shares), and Aberdeen Group plc (188K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.